CORGENIX MEDICAL CORP/CO (CONX) financial statements (2020 and earlier)

Company profile

Business Address 11575 MAIN STREET
BROOMFIELD, CO 80020
State of Incorp. CO
Fiscal Year End June 30
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
Q2
9/30/2014
Q1
6/30/2014
Q4
3/31/2014
Q3
12/31/2013
Q2
9/30/2013
Q1
6/30/2013
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2323222
Cash and cash equivalents2323222
Receivables2121232
Inventory, net of allowances, customer advances and progress billings2222222
Inventory2222222
Prepaid expense000    
Prepaid expense and other current assets0000
Other undisclosed current assets00000(1)(1)
Total current assets:7666656
Noncurrent Assets
Property, plant and equipment1111111
Long-term investments and receivables  0  00
Due from related parties  0  00
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Other noncurrent assets000    
Prepaid expense and other noncurrent assets0000
Total noncurrent assets:1111211
TOTAL ASSETS:8788777
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2111111
Accounts payable1111010
Accrued liabilities0000000
Employee-related liabilities0000000
Debt0000000
Other undisclosed current liabilities     0 
Total current liabilities:2111111
Noncurrent Liabilities
Long-term debt and lease obligation0000000
Capital lease obligations0000000
Other undisclosed noncurrent liabilities0000000
Total noncurrent liabilities:0000100
Total liabilities:2222111
Stockholders' equity
Stockholders' equity attributable to parent, including:6566665
Additional paid in capital22222222222222
Accumulated deficit(16)(17)(16)(16)(16)(16)(16)
Other undisclosed stockholders' equity attributable to parent0000000
Other undisclosed stockholders' equity      0
Total stockholders' equity:6566665
TOTAL LIABILITIES AND EQUITY:8788777

Income statement (P&L) ($ in millions)

12/31/2014
Q2
9/30/2014
Q1
6/30/2014
Q4
3/31/2014
Q3
12/31/2013
Q2
9/30/2013
Q1
6/30/2013
Q4
Revenues
(Revenue, Net)
4232332
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)(1)(2)(1)
Gross profit:2121111
Operating expenses(2)(2)(1)(1)(1)(1)(1)
Operating income (loss):0(1)0000(0)
Nonoperating expense(0)(0)(0)(0)(0)(0)(0)
Other nonoperating income (expense) (0) 000 
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:0(1)0000(0)
Other undisclosed income from continuing operations before income taxes000000 
Income (loss) from continuing operations before income taxes:0(1)0000(0)
Income tax expense (benefit) 0   (0) 
Net income (loss):0(1)0000(0)
Other undisclosed net income attributable to parent      0
Net income (loss) attributable to parent:0(1)0000(0)
Other undisclosed net income (loss) available to common stockholders, basic433(773)     
Net income (loss) available to common stockholders, diluted:434(774)0000(0)

Comprehensive Income ($ in millions)

12/31/2014
Q2
9/30/2014
Q1
6/30/2014
Q4
3/31/2014
Q3
12/31/2013
Q2
9/30/2013
Q1
6/30/2013
Q4
Net income (loss):0(1)0000(0)
Comprehensive income (loss), net of tax, attributable to parent:0(1)0000(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: